Codexis Net Income
| CDXS Stock | USD 1.20 0.02 1.69% |
As of the 15th of February 2026, Codexis shows the risk adjusted performance of (0.07), and Mean Deviation of 3.72. Codexis technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Codexis market risk adjusted performance and treynor ratio to decide if Codexis is priced correctly, providing market reflects its regular price of 1.2 per share. Given that Codexis is a hitting penny stock territory we recommend to closely look at its jensen alpha.
Codexis Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.2181 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -58.7 M | -55.8 M | |
| Net Loss | -58.7 M | -55.8 M | |
| Net Loss | -38.6 M | -40.6 M | |
| Net Loss | (0.80) | (0.84) | |
| Net Income Per E B T | 1.15 | 1.10 |
Codexis | Net Income | Build AI portfolio with Codexis Stock |
The evolution of Net Income for Codexis provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Codexis compares to historical norms and industry peers.
Latest Codexis' Net Income Growth Pattern
Below is the plot of the Net Income of Codexis over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Codexis financial statement analysis. It represents the amount of money remaining after all of Codexis operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Codexis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Codexis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (65.28 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Codexis Net Income Regression Statistics
| Arithmetic Mean | (30,785,669) | |
| Coefficient Of Variation | (69.15) | |
| Mean Deviation | 17,215,023 | |
| Median | (22,996,000) | |
| Standard Deviation | 21,286,970 | |
| Sample Variance | 453.1T | |
| Range | 68.7M | |
| R-Value | (0.64) | |
| Mean Square Error | 288.2T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | (2,678,256) | |
| Total Sum of Squares | 7250.2T |
Codexis Net Income History
Other Fundumenentals of Codexis
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Codexis Net Income component correlations
Codexis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Codexis is extremely important. It helps to project a fair market value of Codexis Stock properly, considering its historical fundamentals such as Net Income. Since Codexis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Codexis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Codexis' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Life Sciences Tools & Services market expansion? Will Codexis introduce new products? Factors like these will boost the valuation of Codexis. Projected growth potential of Codexis fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Codexis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.73) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
The market value of Codexis is measured differently than its book value, which is the value of Codexis that is recorded on the company's balance sheet. Investors also form their own opinion of Codexis' value that differs from its market value or its book value, called intrinsic value, which is Codexis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Codexis' market value can be influenced by many factors that don't directly affect Codexis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Codexis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Codexis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Codexis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Codexis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Codexis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Codexis.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Codexis on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Codexis or generate 0.0% return on investment in Codexis over 90 days. Codexis is related to or competes with Mettler Toledo, Alcon AG, ResMed, Haleon Plc, Cardinal Health, Becton Dickinson, and Insmed. Codexis, Inc. discovers, develops, and sells enzymes and other proteins More
Codexis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Codexis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Codexis upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 22.77 | |||
| Value At Risk | (7.74) | |||
| Potential Upside | 6.21 |
Codexis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Codexis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Codexis' standard deviation. In reality, there are many statistical measures that can use Codexis historical prices to predict the future Codexis' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.18) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Codexis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Codexis February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.17) | |||
| Mean Deviation | 3.72 | |||
| Coefficient Of Variation | (1,061) | |||
| Standard Deviation | 4.82 | |||
| Variance | 23.26 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.18) | |||
| Maximum Drawdown | 22.77 | |||
| Value At Risk | (7.74) | |||
| Potential Upside | 6.21 | |||
| Skewness | 0.0917 | |||
| Kurtosis | 2.0 |
Codexis Backtested Returns
Codexis secures Sharpe Ratio (or Efficiency) of -0.0764, which signifies that the company had a -0.0764 % return per unit of standard deviation over the last 3 months. Codexis exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Codexis' risk adjusted performance of (0.07), and Mean Deviation of 3.72 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.64, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Codexis will likely underperform. At this point, Codexis has a negative expected return of -0.34%. Please make sure to confirm Codexis' treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Codexis performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.24 |
Weak predictability
Codexis has weak predictability. Overlapping area represents the amount of predictability between Codexis time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Codexis price movement. The serial correlation of 0.24 indicates that over 24.0% of current Codexis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Codexis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Codexis reported net income of (65.28 Million). This is 119.13% lower than that of the Life Sciences Tools & Services sector and 193.19% lower than that of the Health Care industry. The net income for all United States stocks is 111.43% higher than that of the company.
Codexis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Codexis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Codexis could also be used in its relative valuation, which is a method of valuing Codexis by comparing valuation metrics of similar companies.Codexis is currently under evaluation in net income category among its peers.
Codexis Institutional Holders
Institutional Holdings refers to the ownership stake in Codexis that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Codexis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Codexis' value.| Shares | Baillie Gifford & Co Limited. | 2025-06-30 | 1.7 M | State Street Corp | 2025-06-30 | 1.6 M | Jacobs Levy Equity Management, Inc. | 2025-06-30 | 1.2 M | Federated Hermes Inc | 2025-06-30 | 872.8 K | Renaissance Technologies Corp | 2025-06-30 | 755.5 K | Prescott Group Capital Management Llc | 2025-06-30 | 700.6 K | Northern Trust Corp | 2025-06-30 | 659.2 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 572.1 K | Private Advisor Group, Llc | 2025-06-30 | 522.9 K | Opaleye Management Inc | 2025-06-30 | 12.6 M | Casdin Capital, Llc | 2025-06-30 | 7.2 M |
Codexis Fundamentals
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (1.21) % | ||||
| Operating Margin | (2.20) % | ||||
| Current Valuation | 117.41 M | ||||
| Shares Outstanding | 90.32 M | ||||
| Shares Owned By Insiders | 2.60 % | ||||
| Shares Owned By Institutions | 71.82 % | ||||
| Number Of Shares Shorted | 6.45 M | ||||
| Price To Earning | (16.02) X | ||||
| Price To Book | 2.79 X | ||||
| Price To Sales | 2.05 X | ||||
| Revenue | 59.34 M | ||||
| Gross Profit | (10.7 M) | ||||
| EBITDA | (58.52 M) | ||||
| Net Income | (65.28 M) | ||||
| Cash And Equivalents | 90.11 M | ||||
| Cash Per Share | 1.38 X | ||||
| Total Debt | 59.9 M | ||||
| Debt To Equity | 0.29 % | ||||
| Current Ratio | 4.84 X | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (49.41 M) | ||||
| Short Ratio | 6.64 X | ||||
| Earnings Per Share | (0.73) X | ||||
| Price To Earnings To Growth | (1.16) X | ||||
| Target Price | 6.58 | ||||
| Number Of Employees | 188 | ||||
| Beta | 2.47 | ||||
| Market Capitalization | 108.39 M | ||||
| Total Asset | 149.01 M | ||||
| Retained Earnings | (562.81 M) | ||||
| Working Capital | 75.12 M | ||||
| Current Asset | 32.84 M | ||||
| Current Liabilities | 14.84 M | ||||
| Net Asset | 149.01 M |
About Codexis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Codexis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Codexis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Codexis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.